| 32700671
|
Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2. |
Euro Surveill |
2020 |
Zheng Z;Monteil VM;Maurer-Stroh S;Yew CW;Leong C;Mohd-Ismail NK;Cheyyatraivendran Arularasu S;Chow VTK;Lin RTP;Mirazimi A;Hong W;Tan YJ |
View
More |
| 32948116
|
Identification of potential inhibitors of SARS-CoV-2 main protease and spike receptor from 10 important spices through structure-based virtual screening and molecular dynamic study. |
J Biomol Struct Dyn |
2022 |
Sen D;Debnath P;Debnath B;Bhaumik S;Debnath S |
View
More |
| 33049711
|
Using the common cold virus as a naturally occurring vaccine to prevent COVID-19: Lessons from Edward Jenner. |
Aging (Albany NY) |
2020 |
Sotgia F;Lisanti MP |
View
More |
| 33128877
|
Unbiased Screens Show CD8(+) T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein. |
Immunity |
2020 |
Ferretti AP;Kula T;Wang Y;Nguyen DMV;Weinheimer A;Dunlap GS;Xu Q;Nabilsi N;Perullo CR;Cristofaro AW;Whitton HJ;Virbasius A;Olivier KJ Jr;Buckner LR;Alistar AT;Whitman ED;Bertino SA;Chattopadhyay S;MacBeath G |
View
More |
| 33409271
|
Design, Expression, Purification, and Characterization of a YFP-Tagged 2019-nCoV Spike Receptor-Binding Domain Construct. |
Front Bioeng Biotechnol |
2020 |
Bierig T;Collu G;Blanc A;Poghosyan E;Benoit RM |
View
More |
| 33582369
|
Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay. |
Int J Infect Dis |
2021 |
Echeverria G;Guevara A;Coloma J;Ruiz AM;Vasquez MM;Tejera E;de Waard JH |
View
More |
| 33767706
|
The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic. |
Front Immunol |
2021 |
Shah P;Canziani GA;Carter EP;Chaiken I |
View
More |
| 33842877
|
Conformational Changes of the Receptor Binding Domain of SARS-CoV-2 Spike Protein and Prediction of a B-Cell Antigenic Epitope Using Structural Data. |
Front Artif Intell |
2021 |
Khare S;Azevedo M;Parajuli P;Gokulan K |
View
More |
| 33961065
|
Current understanding on molecular drug targets and emerging treatment strategy for novel coronavirus-19. |
Naunyn Schmiedebergs Arch Pharmacol |
2021 |
Raj K;Kaur K;Gupta GD;Singh S |
View
More |
| 34012431
|
CD4(+) T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein. |
Front Immunol |
2021 |
Taborska P;Strizova Z;Stakheev D;Sojka L;Bartunkova J;Smrz D |
View
More |
| 34466204
|
Isolation of Antibodies Against the Spike Protein of SARS-CoV from Pig Serum for Competitive Immunoassay. |
Biochip J |
2021 |
Jung J;Bong JH;Kim TH;Sung JS;Lee C;Kang MJ;Kim HO;Shin HJ;Pyun JC |
View
More |
| 34695328
|
[Overview of the current situation regarding the coronavirus]. |
Rev Med Inst Mex Seguro Soc |
2020 |
Zaragoza-Martinez F;Lucho-Constantino GG;Barrales-Cureno HJ |
View
More |
| 34808196
|
A reduced graphene oxide-Fe(3)O(4) composite functionalized with cetyltrimethylammonium bromide for efficient adsorption of SARS-CoV-2 spike pseudovirus and human enteric viruses. |
Chemosphere |
2022 |
Zhou S;Jin M;Tan R;Shen Z;Yin J;Qiu Z;Chen Z;Shi D;Li H;Yang Z;Wang H;Gao Z;Li J;Yang D |
View
More |
| 35269703
|
A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody. |
Int J Mol Sci |
2022 |
Scheim DE |
View
More |
| 36064407
|
Immunomolecular assay based on selective virion capture by spike antibody and viral nucleic acid amplification for detecting intact SARS-CoV-2 particles. |
J Nanobiotechnology |
2022 |
Wu X;Liu J;Zhang H;Zhou H;Wang W;Ma Y;Shen S;Cai X;Huang A;Wang D |
View
More |
| 36762857
|
Cryo-EM reveals binding of linoleic acid to SARS-CoV-2 spike glycoprotein, suggesting an antiviral treatment strategy. |
Acta Crystallogr D Struct Biol |
2023 |
Toelzer C;Gupta K;Berger I;Schaffitzel C |
View
More |
| 37705731
|
The FDA-approved drug nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on the viral spike glycoprotein. |
Front Microbiol |
2023 |
Piacentini S;Riccio A;Santopolo S;Pauciullo S;La Frazia S;Rossi A;Rossignol JF;Santoro MG |
View
More |
